Skip to main content
Caplight Logo









CureSee

CureSee

Private
IndiaHealthcare & Life Scienceshttps://curesee.com/

Last Round

Angel

Feb 16, 2023

Est. Valuation

$600,000

Total Funding Raised

$84,000

Company Overview

CureSee is a health-tech company that provides an AI-based vision therapy software platform for treating conditions such as amblyopia, squint eye, and convergence insufficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Telemedicine, Patient Engagement, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

vision therapydigital vision therapylazy eye treatmentamblyopia therapyremote patient monitoringRPMbinocular vision traininggamified therapyAI vision therapydichoptic therapycomputer vision syndromeconvergence insufficiencyhealth-techtelemedicinehome-based therapyeye exercises

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureSee Comparables

Compare CureSee with similar companies based on industry and business-model similarity.

CureSee comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bynocs
90%
RevitalVision
83%
Vivid Vision
82%

CureSee Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelFeb 16, 2023

Key People

Founding team and executive leadership

Amit Sahni

Co-Founder & COO

Founding Team

Puneet .

Co-Founder & CEO

Founding Team

CureSee Investors

Notable investors and investment history

CureSee investors
InvestorRounds
Ministry of Electronics and Information TechnologyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors increased 69% MoM, reaching 14.8K.

  • Mar 2, 2026

    Monthly visitors increased 207% MoM, reaching 8.7K.

CureSee Filings

Explore SEC and related filing metadata, where available.

CureSee filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CureSee's valuation, stock price, and market status.

Is CureSee a public or private company?

CureSee is a private company.

What is the current stock price of CureSee?

CureSee is a private company with no public stock price. No recent secondary market data is available.

How much is CureSee worth (valuation)?

CureSee's valuation is estimated at $600.0K based on funding round data.

Can I buy CureSee stock?

CureSee shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CureSee's last funding round?

CureSee's most recent funding round was Angel on February 16, 2023.

Who are the main investors in CureSee?

Key investors in CureSee include Ministry of Electronics and Information Technology.

Will CureSee IPO soon?

No public IPO plans have been announced for CureSee.

How can I track CureSee secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureSee's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIndia
Employee Range6
Year Founded2019
Last FundingFeb 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?